Wachovia thinks Teva Phama's (Nasdaq: TEVA) buyout of Barr (NYSE: BRL) could spin Mylan (NYSE: MYL) into action.
This article: 92 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE